Brief: Laurus Labs Says Unit Underwent Us FDA Inspection For Manufacturing Facility In Parawada, Andhra Pradesh
12/12/2023 12:44
Dec 12 (Reuters) - Laurus Labs Ltd LAUL.NS :
* UNIT UNDERWENT US FDA INSPECTION FOR MANUFACTURING FACILITY IN PARAWADA
ANDHRA
PRADESH
* ISSUED FORM 483 WITH FIVE OBSERVATIONS AFTER INSPECTION
Further company coverage: LAUL.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Laurus Labs
See all newsIndia's Laurus Labs hits record high as Q2 profit more than doubles
Brief: Laurus Labs Declares Dividend Of 1 Rupee Per Share
Brief: Laurus Labs Invests 1.08 Billion Rupees Into KRKA Pharma Via Rights Issue
Brief: Laurus Labs Invests 120.96 Million Rupees In Kurnool Renewables Via Rights Issue
Four Indian stocks to be added, three removed from key global index in MSCI's August rejig